Cognitive Effects of Memantine in Postmenopausal Women at Risk of Dementia: a Pilot Study
Phase of Trial: Phase II
Latest Information Update: 24 May 2017
At a glance
- Drugs Memantine (Primary)
- Indications Dementia
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 05 Jun 2012 Actual patient number 30 and lead trial investigator (Rasgon N) added as reported by ClinicalTrials.gov.
- 05 Jun 2012 Actual end date (December 2009) added as reported by ClinicalTrials.gov.